Plasma Level Monitoring of DOACs: Balancing Bleeding and Thrombosis Risk
Pall T. Onundarson, Professor Emeritus at Landspitali University Hospital, reposted from Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:
“20 years ago nobody would have been surprised. How else to explain their effect?”
Quoting Journal of Thrombosis and Haemostasis (JTH)’s post on LinkedIn:
“Plasma levels measurement of the 4 direct oral anticoagulants in patients with atrial fibrillation at the time of acute thromboembolic and bleeding events․
This prospective study of 1794 patients with nonvalvular atrial fibrillation found significant interindividual variability in plasma levels of direct oral anticoagulants (DOACs). Low DOAC plasma levels were associated with increased thromboembolic events, while high levels correlated with bleeding events, suggesting plasma level monitoring could help tailor treatment to minimize adverse outcomes.”
Title: Plasma levels measurement of the 4 direct oral anticoagulants in patients with atrial fibrillation at the time of acute thromboembolic and bleeding events
Authors: Cosmo Godino, Riccardo Mazza, Carlo Gaspardone, Alessia Minerva, Rachele Sena, Gianmarco Cozzani, Anna Salerno, Michela Cera, Massimo Slavich, Leila Anna De Lorenzo, Giulio Leo, Giulia Nemola, Annalisa Fattorini, Luciano Crippa, Patrizia Della Valle, Alberto Margonato, Armando D’Angelo
Read the full article here.
Stay updated with Hemostasis Today.
-
May 24, 2026, 13:46Sergio Emanuel Kaiser: A Whole New Array of Potent Oral PCSK9 Inhibitors
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View
-
May 24, 2026, 11:28Ratiporn Chinthammit: A Meaningful Exchange in aHUS and PNH Education
-
May 24, 2026, 11:17Mary Ann Sromoski: Transfusion Medicine and Patient Blood Management in Practice
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke